While the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) recommend a bivalent booster for anyone over the age of 6 months, some physicians disagree.
This includes clinicians who discourage all COVID-19 vaccinations, and also those who endorse the primary shots but have reservations about boosting.
Dr. Paul Offit, an FDA committee advisor, on Jan. 11 discouraged bivalent boosters for young and healthy people in a commentary in the New England Journal of Medicine.
Offit, however, as a pediatrician, has voted to approve primary series vaccines for all age groups in previous advisory meetings.
“The landscape is different now” in January 2023 than it was in January 2022 or 2021, said pediatric disease specialist Dr. Cody Meissner, another FDA advisory committee member and professor of pediatrics at Dartmouth’s Geisel School of Medicine. “The equation changes as time goes by.”…